Citation Impact
Citing Papers
Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis
2023 StandoutNobel
Genetic determinants of hepatic steatosis in man
2011
Targeted Drug Delivery to Hepatic Stellate Cells for the Treatment of Liver Fibrosis
2019
Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis
2012
Immunonutrition: role of biosurfactants, fiber, and probiotic bacteria
1998
Mechanisms of hepatic stellate cell activation
2017 Standout
The Role of Cholesterol in the Pathogenesis of NASH
2015
Hallmarks of aging: An expanding universe
2023 Standout
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
New Imaging Techniques for Non-Alcoholic Steatohepatitis
2009
Hepatocellular carcinoma
2021 Standout
Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer
2016 Standout
Recent insights on the role of cholesterol in non-alcoholic fatty liver disease
2015
Nonalcoholic fatty liver disease in type 2 diabetes mellitus
2009
Deletion of Nrf2 leads to rapid progression of steatohepatitis in mice fed atherogenic plus high-fat diet
2012
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis
2016
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
2016 Standout
Wnt signaling pathway in aging-related tissue fibrosis and therapies
2020
Suramin inhibits hepatic tissue damage in hepatocellular carcinoma through deactivation of heparanase enzyme
2014
Mechanisms of Hepatic Fibrogenesis
2008 Standout
Specific Contribution of Methionine and Choline in Nutritional Nonalcoholic Steatohepatitis
2010
Micheliolide, a new sesquiterpene lactone that inhibits intestinal inflammation and colitis-associated cancer
2014
The Nrf2 regulatory network provides an interface between redox and intermediary metabolism
2014 Standout
Animal models of nonalcoholic fatty liver disease
2010
Donor evaluation and hepatectomy for living-donor liver transplantation
2008
Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis
2020
Adiponectin Regulation and Function
2018
Potential commercial applications of microbial surfactants
2000 Standout
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
2019 Standout
Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT
2012
Recent advances in nonalcoholic fatty liver disease
2009
The Clavien-Dindo Classification of Surgical Complications
2009 Standout
Adipokines in liver diseases #
2009
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Role of Cholesterol‐Associated Steatohepatitis in the Development of NASH
2021
Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum
2016
Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysis
2017 Standout
Adipokines in Nonalcoholic Steatohepatitis: From Pathogenesis to Implications in Diagnosis and Therapy
2009
Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research
2020 Standout
Pathophysiology of Type 2 Diabetes Mellitus
2020 Standout
Deletion of nuclear factor-E2-related factor-2 leads to rapid onset and progression of nutritional steatohepatitis in mice
2009
Lipotoxicity and the gut-liver axis in NASH pathogenesis
2017
Review article: emerging anti‐fibrotic therapies in the treatment of non‐alcoholic steatohepatitis
2016
Moderate to vigorous physical activity volume is an important factor for managing nonalcoholic fatty liver disease: A retrospective study
2014
Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
2020
Human Fatty Liver Disease: Old Questions and New Insights
2011 StandoutScience
Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.
2011 StandoutNobel
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Nonalcoholic Fatty Liver Disease
2015 Standout
Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI
2023 StandoutNobel
Works of Rie Irie being referenced
Discontinuation of Living Donor Liver Transplantation for PSC Due to Histological Abnormalities in Intraoperative Donor Liver Biopsy
2007
Aortic carboxypeptidase–like protein, a WNT ligand, exacerbates nonalcoholic steatohepatitis
2018
Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice†
2008
A High-Cholesterol Diet Exacerbates Liver Fibrosis in Mice via Accumulation of Free Cholesterol in Hepatic Stellate Cells
2011
Castleman’s disease arising from the gallbladder neck causing difficulty in the differential diagnosis
2010
Evaluating the severity of nonalcoholic steatohepatitis with superparamagnetic iron oxide‐enhanced magnetic resonance imaging
2008
Candidate Molecular Markers for Histological Diagnosis of Early Hepatocellular Carcinoma
2008
Significant immunosuppressive effect of ganglioside GM3 in organ transplantation.
1990